Live Breaking News & Updates on Pittsburgh Vasculitis Center

Compared with conventional synthetic disease-modifying antirheumatic drugs (DMARDs), biologic and targeted synthetic DMARDs may lower dementia risk. ....

United States , Sebastiane Sattui , Centers For Medicare Medicaid Services , Prior Research , University Of Pittsburgh , National Institutes Of Health , National Institute On , University Of Pittsburgh Vasculitis Center , Pittsburgh Vasculitis Center , Medicaid Services , National Institutes , National Institute , Rheumatoid Arthritis , Disease Modifying Antirheumatic Drugs Dmards , Mard Disease Modifying Antirheumatic Drug , Biologic Therapy , Ankylosing Spondylitis , Oint Inflammation , Healthcare Technology , Ealth Care Technology , Tnf Alpha , Tumor Necrosis Factor Alpha , Umor Necrosis Factor Tnf , Crohns Disease , Practice Management ,